학술논문
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study
Document Type
Article
Author
Bertucci, François; Fekih, Mahmoud; Autret, Aurélie; Petit, Thierry; Dalenc, Florence; Levy, Christelle; Romieu, Gilles; Bonneterre, Jacques; Ferrero, Jean-Marc; Kerbrat, Pierre; Soulie, Patrick; Mouret-Reynier, Marie-Ange; Bachelot, Thomas; Lerebours, Florence; Eymard, Jean-Christophe; Deblock, Mathilde; Lortholary, Alain; Hardy-Bessard, Anne-Claire; Barthelemy, Philippe; Bonnefoi, Hervé; Charafe-Jauffret, Emmanuelle; Bidard, François-Clément; Viens, Patrice; Lemonnier, Jérôme; Pierga, Jean-Yves
Source
In The Lancet Oncology May 2016 17(5):600-611
Subject
Language
ISSN
1470-2045